181 related articles for article (PubMed ID: 34336653)
1. Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Haritha NH; Nawab A; Vijayakurup V; Anto NP; Liju VB; Alex VV; Amrutha AN; Aiswarya SU; Swetha M; Vinod BS; Sundaram S; Guijarro MV; Herlevich T; Krishna A; Nestory NK; Bava SV; Sadasivan C; Zajac-Kaye M; Anto RJ
Front Oncol; 2021; 11():656804. PubMed ID: 34336653
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil.
Vinod BS; Antony J; Nair HH; Puliyappadamba VT; Saikia M; Narayanan SS; Bevin A; Anto RJ
Cell Death Dis; 2013 Feb; 4(2):e505. PubMed ID: 23429291
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH; Nawab A; Vijayakurup V; Anto NP; Liju VB; Alex VV; Amrutha AN; Aiswarya SU; Swetha M; Vinod BS; Sundaram S; Guijarro MV; Herlevich T; Krishna A; Nestory NK; Bava SV; Sadasivan C; Zajac-Kaye M; Anto RJ
Front Oncol; 2023; 13():1302413. PubMed ID: 38162481
[TBL] [Abstract][Full Text] [Related]
4. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
Raymond E; Buquet-Fagot C; Djelloul S; Mester J; Cvitkovic E; Allain P; Louvet C; Gespach C
Anticancer Drugs; 1997 Oct; 8(9):876-85. PubMed ID: 9402315
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
10. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2
Yi J; Chen S; Yi P; Luo J; Fang M; Du Y; Zou L; Fan P
Oncol Res; 2020 Dec; 28(5):519-531. PubMed ID: 32727638
[TBL] [Abstract][Full Text] [Related]
11. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase predicts for clinical outcome in invasive breast cancer.
Yu Z; Sun J; Zhen J; Zhang Q; Yang Q
Histol Histopathol; 2005 Jul; 20(3):871-8. PubMed ID: 15944938
[TBL] [Abstract][Full Text] [Related]
13. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
14. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
15. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
Sakurai Y; Uraguchi T; Imazu H; Hasegawa S; Matsubara T; Ochiai M; Funabiki T
Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
Ide H; Kikuchi E; Hasegawa M; Hattori S; Yasumizu Y; Miyajima A; Oya M
Cancer Med; 2013 Aug; 2(4):488-95. PubMed ID: 24156021
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
19. Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
Brody JR; Hucl T; Costantino CL; Eshleman JR; Gallmeier E; Zhu H; van der Heijden MS; Winter JM; Wikiewicz AK; Yeo CJ; Kern SE
Cancer Res; 2009 Feb; 69(3):984-91. PubMed ID: 19155291
[TBL] [Abstract][Full Text] [Related]
20. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
Zheng X; Yang X; Lin J; Song F; Shao Y
Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
